These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32927595)

  • 1. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.
    Vigani B; Rossi S; Sandri G; Bonferoni MC; Caramella CM; Ferrari F
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ gelling and mucoadhesive polymers: why do they need each other?
    Zahir-Jouzdani F; Wolf JD; Atyabi F; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2018 Oct; 15(10):1007-1019. PubMed ID: 30173567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics.
    Rana SJ; Zafar S; Shahzad A; Basit M; Mudassir J; Akhlaq M; Chohan TA; Arshad MS
    AAPS PharmSciTech; 2023 Nov; 24(8):242. PubMed ID: 38017208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ gelling polymers in ocular drug delivery systems: a review.
    Mundada AS; Avari JG
    Crit Rev Ther Drug Carrier Syst; 2009; 26(1):85-118. PubMed ID: 19496748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancement in stimuli triggered in situ gelling delivery for local and systemic route.
    Ajazuddin ; Alexander A; Khan J; Giri TK; Tripathi DK; Saraf S; Saraf S
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1573-92. PubMed ID: 23075325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gelling drug delivery systems for topical drug delivery.
    Kolawole OM; Cook MT
    Eur J Pharm Biopharm; 2023 Mar; 184():36-49. PubMed ID: 36642283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ forming polymeric drug delivery systems.
    Madan M; Bajaj A; Lewis S; Udupa N; Baig JA
    Indian J Pharm Sci; 2009 May; 71(3):242-51. PubMed ID: 20490289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status of Mucoadhesive Gel Systems for Buccal Drug Delivery.
    Okur NÜ; Bülbül EÖ; Yağcılar AP; Siafaka PI
    Curr Pharm Des; 2021; 27(17):2015-2025. PubMed ID: 33726644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.
    Abdeltawab H; Svirskis D; Sharma M
    Expert Opin Drug Deliv; 2020 Apr; 17(4):495-509. PubMed ID: 32067500
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies to prolong the residence time of drug delivery systems on ocular surface.
    Grassiri B; Zambito Y; Bernkop-Schnürch A
    Adv Colloid Interface Sci; 2021 Feb; 288():102342. PubMed ID: 33444845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
    Singh RM; Kumar A; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNA.
    Park JS; Oh YK; Yoon H; Kim JM; Kim CK
    J Biomed Mater Res; 2002 Jan; 59(1):144-51. PubMed ID: 11745547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Situ Forming Depot as Sustained-Release Drug Delivery Systems.
    Kanwar N; Sinha VR
    Crit Rev Ther Drug Carrier Syst; 2019; 36(2):93-136. PubMed ID: 30806210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery.
    He C; Kim SW; Lee DS
    J Control Release; 2008 May; 127(3):189-207. PubMed ID: 18321604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
    J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel.
    Kesarla R; Tank T; Vora PA; Shah T; Parmar S; Omri A
    Drug Deliv; 2016 Sep; 23(7):2363-2370. PubMed ID: 25579467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoresponsive mucoadhesive hybrid gels in advanced drug delivery systems.
    Mfoafo K; Omidi Y; Omidian H
    Int J Pharm; 2023 Apr; 636():122799. PubMed ID: 36914019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-situ gel: A smart carrier for drug delivery.
    Garg A; Agrawal R; Singh Chauhan C; Deshmukh R
    Int J Pharm; 2024 Mar; 652():123819. PubMed ID: 38242256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising Polymeric Drug Carriers for Local Delivery: The Case of
    Okur NÜ; Yağcılar AP; Siafaka PI
    Curr Drug Deliv; 2020; 17(8):675-693. PubMed ID: 32510291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.